Research and experimental development on natural sciences and engineering
YZ HOLDING AS
Revenue 2024
NOK 290,000
Operating profit
NOK 257,000
Equity
NOK 466,000
Incorporated
2013
Share capital
NOK 50,000
Roles
Revisor
Styrets lederKarl Henning Kalland
StyremedlemAnne Margrete Øyan
StyremedlemBjørn Tore Gjertsen
StyremedlemPhillip Benson Keul
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| BJØRN TORE GJERTSEN | 40.0% | 40000.000000 | 2025 |
| KARL HENNING KALLAND | 30.0% | 30000.000000 | 2025 |
| ANNE MARGRETE ØYAN | 10.0% | 10000.000000 | 2025 |
| ERIC RAGDE | 10.0% | 10000.000000 | 2025 |
| PHILLIP BENSON KEUL | 10.0% | 10000.000000 | 2025 |
Holdings in other companies
| Company | Status | Stake | Shares |
|---|---|---|---|
| ALDEN CANCER THERAPY AS | Active | 58.9% | 66.000000 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.